Cerebain Biotech Corp (CBBT)

Not featured in screeners

Not featured in screeners

Ticker: CBBT Exchange: OTC

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

Tate Wesley D.

Chief Financial Officer

2 purchases — total 89,423 USD

Buy 16 Jun 2014

Value US$4,257,095.96 | Price 330.98 | Shares 61,253

Buy 16 Jun 2014

Value US$3,863,883.35 | Price 312.86 | Shares 55,457

CLEMONS ERIC

President

1 purchase — total 121,016 USD

Buy 31 Dec 2013

Value US$4,536,834.07 | Price 32.27 | Shares 16,232

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2014-06-27	2014-06-16	B Purchase	Tate Wesley D. Chief Financial Officer Executive Director	61,253 +29.0% 330.98 US$4,257,096	61,253 +29.0%	330.98	US$4,257,096
2014-06-27	2014-06-16	B Purchase	Tate Wesley D. Chief Financial Officer Executive Director	55,457 -25.5% 312.86 US$3,863,883	55,457 -25.5%	312.86	US$3,863,883
2014-06-30	2013-12-31	B Purchase	CLEMONS ERIC President Executive Director	16,232 +14.7% 32.27 US$4,536,834	16,232 +14.7%	32.27	US$4,536,834

More insider trading research around Cerebain Biotech Corp